跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
公共衛生學系
臺北醫學大學
公共衛生學院
電話
+886-2-27361661#6509
電子郵件
[email protected]
網站
http://ph.tmu.edu.tw
郵寄地址
在地圖上顯示
No. 250 Wu-Xing Street
11031
Taipei
概覽
指紋
網路
專家檔案
(24)
專案
(354)
研究成果
(1835)
資料集
(59)
活動
(1)
指紋
查看啟用 公共衛生學系 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Adolescent
13%
Adverse Event
10%
Alcohol Consumption
7%
Apoplexy
68%
Atherosclerosis
8%
Atmospheric Aerosol
21%
Biological Marker
20%
Birth Outcomes
10%
Blackfoot Disease
8%
Bladder Cancer
9%
Blood Pressure
12%
Body Mass Index
16%
Brain Ischemia
41%
Breast Cancer
13%
Cancer Risk
14%
Cardiovascular Disease
10%
Cardiovascular System
8%
Carotid Atherosclerosis
9%
Case-Control Study
18%
Cerebral Hemorrhage
9%
Cesarean Section
12%
Childbirth
14%
Chronic Kidney Disease
32%
Chronic Obstructive Pulmonary Disease
18%
Cigarette Smoking
17%
Cohort Analysis
60%
Computer Assisted Tomography
11%
COVID-19
19%
Cross Sectional Study
19%
Cytotoxicity
7%
Diabetes
24%
Diabetes Mellitus
21%
Diagnosis
12%
Diagnostic Accuracy
10%
Disease
28%
Disseminated Herpes Zoster
8%
Dose Response
12%
Drug Therapy
9%
Emergency Department
8%
Emphysema
7%
Evidence-Based Medicine
9%
Fine Particulate Matter
7%
Hazard Ratio
28%
Health Care
9%
Health Care Cost
8%
Health Survey
16%
Hemodialysis
7%
Hemoglobin A1c
9%
Hepatocellular Carcinoma
13%
Household
10%
Human Immunodeficiency Virus
12%
Infection
22%
Injury
12%
Intima-Media Thickness
8%
Ischemic Heart Disease
10%
Logistic Regression Analysis
26%
Long-Term Care
16%
Low Birth Weight
15%
Lung Cancer
11%
Lymphocyte
8%
Malignant Neoplasm
30%
Maturity Onset Diabetes of the Young
12%
Medical Care
9%
Medicine
11%
Meta-Analysis
100%
Metabolic Syndrome
10%
Methylation
28%
Monocyte
8%
Mortality Rate
8%
Multilevel Analysis
10%
Network Meta-Analysis
21%
Obstructive Sleep Apnea
13%
Odds Ratio
66%
Oxidative Stress
8%
Particular Matter 2.5
27%
Physical Activity
7%
Polycyclic Aromatic Hydrocarbon
8%
Population
8%
Postoperative Pain
10%
Premature Labor
13%
Prenatal Care
8%
Prevalence
29%
Proportional Hazards Model
16%
Prospective Cohort Study
12%
Proton-Pump Inhibitor
7%
Public Health
13%
Quality of Life
14%
Random Effects Model
7%
Randomized Controlled Trial
60%
Retrospective Cohort Study
13%
Retrospective Study
8%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Small for Gestational Age
11%
Smoking
10%
Survival Rate
9%
Symptom
13%
Systematic Review
79%
Transitional Cell Carcinoma
19%
Urinary System
42%
Well Water
8%
Pharmacology, Toxicology and Pharmaceutical Science
8 Hydroxydeoxyguanosine
9%
Acetylsalicylic Acid
6%
Adverse Event
16%
Antiinfective Agent
11%
Antioxidant
7%
Asthma
7%
Atherosclerosis
9%
Attention Deficit Disorder
8%
Bioaerosol
7%
Biological Marker
31%
Blackfoot Disease
10%
Bladder Cancer
18%
Brain Hemorrhage
8%
Brain Ischemia
35%
Breast Cancer
9%
C Reactive Protein
14%
Cacodylic Acid
14%
Carbon Black
11%
Cardiovascular Disease
30%
Cardiovascular Risk
9%
Carotid Atherosclerosis
17%
Case-Control Study
23%
Cell Viability
6%
Cerebrovascular Disease
9%
Chemotherapy
9%
Chronic Hepatitis B
7%
Chronic Kidney Failure
38%
Chronic Obstructive Lung Disease
30%
Cigarette Smoke
9%
Cigarette Smoking
27%
Cohort Study
93%
Colorectal Cancer
8%
Comorbidity
19%
Cross-Sectional Study
12%
Cytotoxicity
12%
Developmental Delay
14%
Diabetes Mellitus
24%
Disease
55%
Dose-Response Relationship
19%
Emphysema
14%
End Stage Renal Disease
9%
Epidermal Growth Factor Receptor
11%
Ethanol
9%
Glutathione
15%
Health Hazard
12%
Heavy Metal
6%
Heme Oxygenase 1
8%
Hemodialysis
16%
Hepatitis B
8%
Hepatitis B Virus
9%
High Performance Liquid Chromatography
12%
Hyperlipidemia
7%
Infection
22%
Inflammation
43%
Injury
11%
Interleukin 6
16%
Ischemic Heart Disease
14%
Lactate Dehydrogenase
6%
Liver Cell Carcinoma
8%
Long Term Exposure
20%
Low Birth Weight
18%
Lung Cancer
14%
Malignant Neoplasm
45%
Metabolic Syndrome X
10%
Methanearsonic Acid
15%
Mortality Rate
8%
Mouse
24%
Neoplasm
6%
Nitric Oxide
8%
Nitrogen Dioxide
7%
Non Insulin Dependent Diabetes Mellitus
12%
Normal Human
9%
Organic Carbon
11%
Overall Survival
11%
Oyster
11%
Placebo
8%
Polycyclic Aromatic Hydrocarbon
21%
Premature Labor
11%
Prevalence
38%
Prospective Cohort Study
10%
Protein P53
7%
Proton Pump Inhibitor
9%
Randomized Controlled Trial
34%
Reactive Oxygen Metabolite
12%
Recurrent Disease
9%
Renal Cell Carcinoma
9%
Respiratory Tract Disease
7%
Sleep Disordered Breathing
16%
Small for Date Infant
11%
Survival Rate
7%
Symptom
10%
Tigecycline
13%
Transferase
12%
Transitional Cell Carcinoma
43%
Tumor Necrosis Factor
13%
Vaccination Policy
9%
Virus Hepatitis
7%
Volatile Organic Compound
8%
Well Water
28%
Zinc Oxide Nanoparticle
11%
Nursing and Health Professions
Acute Heart Infarction
5%
Adolescent
22%
Analysis of Variance
5%
Asthma
8%
Bibliometrics
14%
Blood Pressure
12%
Body Mass
7%
Brain Ischemia
12%
Breast Cancer
11%
Cardiovascular Disease
13%
Case-Control Study
13%
Chronic Disease
8%
Chronic Hepatitis
5%
Chronic Kidney Failure
12%
Cigarette Filter
20%
Clinical Outcome
5%
Cochrane Library
6%
Cognitive Defect
6%
Cohort Analysis
44%
Comorbidity
9%
Confidence Interval
86%
Cross-Sectional Study
28%
Depression
11%
Diabetes Mellitus
13%
Diagnosis
5%
Diagnostic Accuracy
5%
Disease
29%
Drug Therapy
10%
Gender Difference
10%
Hazard Ratio
14%
Head Injury
7%
Health Care Personnel
16%
Health Care Utilization
5%
Health Literacy
13%
Health Service
15%
Health Status
9%
Health Survey
16%
Hemodialysis
10%
Hemoglobin A1c
5%
Hepatitis B
8%
Hepatitis C
6%
Home Care
7%
Hospital
13%
Human Immunodeficiency Virus
16%
Hyperlipidemia
8%
Independent Practice Association
9%
Infant Mortality
5%
Infection
11%
Injury
12%
Insulin Resistance
5%
Intensive Care Unit
5%
Linear Regression Analysis
6%
Live Birth
6%
Logistic Regression Analysis
30%
Loneliness
9%
Long Term Care
19%
Low Birth Weight
11%
Lung Cancer
5%
Malignant Neoplasm
9%
Medline
7%
Mental Health
11%
Meta Analysis
62%
Metabolic Syndrome X
12%
Methylation
5%
Mortality Rate
10%
Multilevel Analysis
9%
Multivariate Logistic Regression Analysis
7%
National Health Insurance
19%
Network Meta-Analysis
8%
Odds Ratio
59%
Outpatient
8%
Panic
6%
Patient with Type 2 Diabetes
5%
Physician
5%
Postoperative Pain
7%
Practice Guideline
18%
Pregnancy Outcome
14%
Prenatal Care
5%
Prevalence
33%
Prophylaxis
5%
Psychiatrist
5%
Quality of Life
20%
Receiver Operating Characteristic
5%
Reimbursement
7%
Self Care
7%
Severe Acute Respiratory Syndrome
11%
Sleep Disordered Breathing
5%
Socioeconomic Status
7%
Survival Rate
6%
Symptom
19%
Systematic Review
38%
Tobacco Control
5%
Transitional Cell Carcinoma
8%
Traumatic Brain Injury
10%
University Hospital
5%
Vaccination Policy
6%
Vaccine Efficacy
5%
Virus Hepatitis
6%
Virus Infection
5%
World Health Organization
6%